# Wild Cordyceps sinensis exhibits far lower arsenic accumulation and hepatorenal toxicity in mice compared to equivalent dose of inorganic arsenic

**Authors:** Liang Gao, Hongxia Yang, Jinmei Ma, Hongtao Bi, Yuancan Xiao, Cen Li, Lixin Wei

PMC · DOI: 10.3389/fphar.2025.1625045 · Frontiers in Pharmacology · 2025-06-24

## TL;DR

Wild Cordyceps sinensis is safer than inorganic arsenic, causing less liver and kidney damage in mice at the same dose.

## Contribution

Demonstrates the relative safety of wild Cordyceps sinensis compared to inorganic arsenic in terms of hepatorenal toxicity.

## Key findings

- Wild Cordyceps sinensis did not cause significant arsenic accumulation or organ damage in mice.
- Inorganic arsenic caused significant liver and kidney toxicity and pathological changes in mice.
- Wild Cordyceps sinensis is safer than equivalent doses of inorganic arsenic compounds.

## Abstract

Wild Cordyceps sinensis (C. sinensis) is a Chinese medicinal material known for its renal and pulmonary benefits. However, inorganic arsenic in wild Cordyceps sinensis may accumulate in the body following prolonged consumption; therefore, rigorous safety evaluations are needed.

This study compared the impacts of wild Cordyceps sinensis at the maximum clinical dose and equivalent doses of inorganic arsenic (16.36 mg/kg) to its total arsenic dose on organ indices, arsenic accumulation, and functional and pathological changes in the liver and kidney in mice, aiming to explore the safety of consuming wild Cordyceps sinensis. Arsenic accumulation in organs was measured via ICP–MS, while serum markers of liver and kidney functions were assessed via ELISA and biochemical assay kits. Histopathology was observed through H&E staining.

Compared with those in the control group, no significant adverse effects on body weight, organ indices, arsenic accumulation, liver or kidney function, or liver or kidney pathology were observed in the Cordyceps group. In contrast, inorganic arsenic exposure resulted in significant arsenic accumulation in organs, especially in the liver and kidneys (p < 0.01), liver and kidney function impairment (p < 0.01), and pathological changes, including hepatic steatosis, mild edema, balloon degeneration, and renal tubular epithelial cell edema and degeneration, with the aggregation of eosinophils in the renal capsule.

These findings indicate that, at the maximum clinical dose, wild Cordyceps sinensis does not cause measurable hepatorenal toxicity in long-term and exhibits markedly greater safety compared to a mixture of inorganic arsenic compounds (sodium arsenate and sodium arsenite) at an equivalent total arsenic dose.

## Linked entities

- **Chemicals:** sodium arsenate (PubChem CID 47275), sodium arsenite (PubChem CID 443495)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), liver and kidney function impairment (MESH:D056486), edema (MESH:D004487), hepatic steatosis (MESH:D005234)
- **Chemicals:** Arsenic (MESH:D001151), H&amp;E (MESH:D006371), inorganic arsenic (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Ophiocordyceps sinensis (species) [taxon 72228]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12235186/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12235186/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12235186/full.md

---
Source: https://tomesphere.com/paper/PMC12235186